Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

180 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Nonparameningeal head and neck rhabdomyosarcoma in children and adolescents: Lessons from the consecutive International Society of Pediatric Oncology Malignant Mesenchymal Tumor studies.
Orbach D, Mosseri V, Gallego S, Kelsey A, Devalck C, Brenann B, van Noesel MM, Bergeron C, Merks JH, Rechnitzer C, Jenney M, Minard-Colin V, Stevens M. Orbach D, et al. Among authors: merks jh. Head Neck. 2017 Jan;39(1):24-31. doi: 10.1002/hed.24547. Epub 2016 Jul 26. Head Neck. 2017. PMID: 27459057
The AMORE protocol for advanced-stage and recurrent nonorbital rhabdomyosarcoma in the head-and-neck region of children: a radiation oncology view.
Blank LE, Koedooder K, Pieters BR, van der Grient HN, van de Kar M, Buwalda J, Balm AJ, Merks JH, Strackee SD, Freling NJ, Koning CC. Blank LE, et al. Among authors: merks jh. Int J Radiat Oncol Biol Phys. 2009 Aug 1;74(5):1555-62. doi: 10.1016/j.ijrobp.2008.10.029. Epub 2009 Feb 26. Int J Radiat Oncol Biol Phys. 2009. PMID: 19250759
Randomized comparison of intensified six-drug versus standard three-drug chemotherapy for high-risk nonmetastatic rhabdomyosarcoma and other chemotherapy-sensitive childhood soft tissue sarcomas: long-term results from the International Society of Pediatric Oncology MMT95 study.
Oberlin O, Rey A, Sanchez de Toledo J, Martelli H, Jenney ME, Scopinaro M, Bergeron C, Merks JH, Bouvet N, Ellershaw C, Kelsey A, Spooner D, Stevens MC. Oberlin O, et al. Among authors: merks jh. J Clin Oncol. 2012 Jul 10;30(20):2457-65. doi: 10.1200/JCO.2011.40.3287. Epub 2012 Jun 4. J Clin Oncol. 2012. PMID: 22665534 Clinical Trial.
The development of a clinical screening instrument for tumour predisposition syndromes in childhood cancer patients.
Hopman SM, Merks JH, de Borgie CA, Aalfs CM, Biesecker LG, Cole T, Eng C, Legius E, Maher ER, van Noesel MM, Verloes A, Viskochil DH, Wagner A, Weksberg R, Caron HN, Hennekam RC. Hopman SM, et al. Among authors: merks jh. Eur J Cancer. 2013 Oct;49(15):3247-54. doi: 10.1016/j.ejca.2013.06.015. Epub 2013 Jul 12. Eur J Cancer. 2013. PMID: 23855994 Free PMC article.
Conservative approach in localised rhabdomyosarcoma of the bladder and prostate: results from International Society of Paediatric Oncology (SIOP) studies: malignant mesenchymal tumour (MMT) 84, 89 and 95.
Jenney M, Oberlin O, Audry G, Stevens MC, Rey A, Merks JH, Kelsey A, Gallego S, Haie-Meder C, Martelli H. Jenney M, et al. Among authors: merks jh. Pediatr Blood Cancer. 2014 Feb;61(2):217-22. doi: 10.1002/pbc.24727. Epub 2013 Aug 29. Pediatr Blood Cancer. 2014. PMID: 23997024
180 results